Aranesp | Cafepharma

Astellas' Anemia Drug Roxadustat Shows Non-Inferiority to Amgen's Aranesp

Submitted by admin on Mon, 06/08/2020 - 23:36

snippet

Astellas Pharma, based in Tokyo, released the results from the Phase III DOLOMITES trial comparing its roxadustat with Amgen’s Aranesp (darbepoetin alfa) for anemia in non-dialysis dependent (NDD) adults with stage 3-5 chronic kidney disease (CKD).

Source

BioSpace

Headline

Astellas' Anemia Drug Roxadustat Shows Non-Inferiority to Amgen's Aranesp

News Tags

chronic kidney disease

What to Expect From Amgen, Inc. in 2018

Submitted by admin on Sun, 01/21/2018 - 10:40

Source

Motley Fool

Headline

What to Expect From Amgen, Inc. in 2018

News Tags

Will 2018 Be Amgen Inc.'s Best Year Yet?

Submitted by admin on Wed, 01/17/2018 - 10:08

Source

Motley Fool

Headline

Will 2018 Be Amgen Inc.'s Best Year Yet?

News Tags

Amgen blood cell disorder drug meets primary goal in phase 3 trial

Submitted by admin on Tue, 02/16/2016 - 10:01

Source

Yahoo/Reuters

Headline

Amgen blood cell disorder drug meets primary goal in phase 3 trial

News Tags

Amgen's Innovation Counters Biosimilar Pressure

Submitted by admin on Mon, 10/19/2015 - 10:03

Source

Morningstar

Headline

Amgen's Innovation Counters Biosimilar Pressure

News Tags

Amgen, U.S. states in $71 mln settlement over drug marketing

Submitted by admin on Tue, 08/18/2015 - 13:25

Source

Yahoo/Reuters

Headline

Amgen, U.S. states in $71 mln settlement over drug marketing

News Tags

Journalist fights Amgen subpoena in Aranesp class action suit

Submitted by admin on Thu, 08/13/2015 - 14:42

Source

Fierce Pharma

Headline

Journalist fights Amgen subpoena in Aranesp class action suit

News Tags

Amgen Subpoenas a Journalist as it Fights a Shareholder Lawsuit

Submitted by admin on Thu, 06/04/2015 - 20:17

Source

WSJ Pharmalot

Headline

Amgen Subpoenas a Journalist as it Fights a Shareholder Lawsuit

News Tags

Most Popular News Headlines For Wednesday, August 13 2014

Submitted by admin on Thu, 08/14/2014 - 10:11

Source

CP Wire

Headline

News Tags

Most popular news headlines for Wednesday, August 13 2014

The most-clicked news item for Wednesday was “BMS, Pfizer pull out all the stops to give Eliquis sales a Q2 jolt.” This Fierce Pharma Marketing article details the reasons behind increased sales of the bloodthinner Eliquis, and how marketing actions have played a role.

Subscribe to Aranesp